Urinary 5-aminolevulinic acid in lead-exposed children

Biomarkers

Volumn 4, Issue 4, 1999, Pages 281-289

  Sithisarankul, Pornchai ^a   Weaver, Virginia M ^b   Davoli, Cecilia T ^c   Strickland, Paul T ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 aminolevulinic acid; Children; Exposure; Lead

Indexed keywords

AMINOLEVULINIC ACID; BIOLOGICAL MARKER; LEAD;

ARTICLE; CHILD; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; URINALYSIS; VALIDATION PROCESS;

EID: 0032817416     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475099230813     Document Type: Article

References (44)

1. ATSDR (Agency for Toxic Substances and Disease Registry) 1992, Case Studies in Environmental Medicine: Lead Toxicity (US Department of Health & Human Services).
2. AUDESIRK, G. 1985, Effects of lead exposure on the physiology of neurons. Progress in Neurobiology, 24, 199-231.
3. BERNARD, A. and LAUWERYS, R. 1987, Metal-induced alterations of δ-aminolevulinic acid dehydratase. Annals of the New York Academy of Sciences, 514, 41-47.
4. BLOOMER, J.R. and BONKOVSKY, H.L. 1989, The porphyrias. Disease-a-Month, 35(1), 1-54.
5. BOENIGER, M.F. LOWRY, L. and ROSENBERG, J. 1993, Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. American Industrial Hygiene Association Journal, 54(10), 615-627.
6. BONKOWSKY, H.L. and SCHADY, W. 1982, Neurologic manifestations of acute porphyria. Seminars in Liver Disorders, 2, 108-124.
7. BOTTA, A., BRUGUEROLLE, B., BARTOLIN, R. and BOUVENOT, 1987, A chronological study of delta-amino levulinic acid urinary excretion. Chronobiology International, 4(4), 509-512.
8. BRENNAN, M.J.W. and CANTRILL, R.C. 1979, δ-Aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature, 280, 514-515.
9. BRENNAN, M.J.W. and CANTRILL, R.C. 1981, Delta-aminolevulinic acid and aminoacid neurotransmitters. Molecular and Cell Biochemistry, 38, 49-58.
10. CDC (Centers for Disease Control) 1991, Preventing lead poisoning in young children: A statement by the Centers for Disease Control. US Department of Health & Human Services.
11. CHISOLM, J.J. Jr 1968, Determination of δ-aminolevulinic acid in plasma. Analytical Biochemistry, 22, 54-64.
12. CHISOLM, J.J., MELLITS, E.D. and BARRETT, M.B. 1976, Interrelationships among blood lead concentration, quantitative daily ALA-U, and urinary lead output following calcium DTA. In Effects and Dose-Response Relationships of Toxic Metals, G.F. Nordberg, ed. (Amsterdam: Elsevier Science Publishers), pp. 416-433.
13. CUTLER, M.G., MCLAUGHLIN, M., MCNEIL, E. and MOORE, M.R. 1985, Effects of delta-aminolaevulinic acid on contractile activity in the isolated small intestine of the rabbit. Neuropharmacology, 24, 1005-1009.
14. DOSS, M., VON TIEPERMANN, R., SCHNEIDER, J. and SCHMID, H. 1979, New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klinische Wochenschrift, 57, 1123-1127.
15. DOSS, M., BECKER, U., SIXEL, F., GEISSE, S., SOLCHER, H., SCHNEIDER, J., KUFNER, G. et al. 1982, Persistent protoporphyrinemia in hereditary porphobilinogen synthase (δ-aminolevulinic acid dehydratase) deficiency under low lead exposure. Klinische Wochenschrift, 60, 599-606.
16. DOSS, M., LAUBENTHAL, F. and STOEPPLER, M. 1984, Lead poisoning in inherited δ-aminolevulinic acid dehydratase deficiency. International Archives of Occupational and Environmental Health, 54, 55-63.
17. HASSOUN, A., VERSTRAETEN, L., MERCELIS, R. and MARTIN, J.J. 1989, Biochemical diagnosis of an hereditary aminolaevulinate dehydratase deficiency in a 63-year-old man. Journal of Clinical Chemistry and Clinical Biochemistry, 27, 781-786.
18. HO, J., GUTHRIE, R. and TEICKELMANN, H. 1986, Detection of δ-aminolevulinic acid, porphobilinogen and porphyrins related to heme biosynthesis by high-performance liquid chromatography. Journal of Chromatography, 375, 57-63.
19. HUDÁK, A., KISS, G., NÁRAY, M. and SÜVEGES, E. 1994, Evaluation of delta-aminolaevulinic acid excretion in random urine samples of children. European Journal of Pediatrics, 153, 187-189.
20. KAPPAS, A., SASSA, S., GALBRAITH, R.A. and NORDMANN, Y. 1995, The porphyrias. In The Metabolic and Molecular Bases of Inherited Disease, Vol. 2, 7th edition, C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle, eds (New York: McGraw-Hill, pp. 2103-2159.
21. LETOURNEAU, G.G., PLANTE, R. and WEBER, J.P. 1988, Blood lead and maximal urinary excretion of delta-aminolevulinic acid. American Industrial Hygiene Association Journal, 49(7), 342-345.
22. MACGEE, J., RODA, S.M.B., ELIAS, S.V., LINGTON, A., TABOR, M.W. and HAMMOND, P.B. 1977, Determination of δ-aminolevulinic acid in blood plasma and urine by gas-liquid chromatography. Biochemical Medicine, 17, 31-44.
23. MAUZERALL, D. and GRANICK, S. 1956, The occurrence and determination of δ-aminolevulinic acid and porphobilinogen in urine. Journal of Biological Chemistry, 219, 435-446.
24. MCGILLION, F.B., THOMPSON, G.G., MOORE, M.R. and GOLDBERG, A. 1974, The passage of δ-aminolaevulinic acid across the blood-brain barrier of the rat: effect of ethanol. Biochemisrty and Pharmacology, 23, 472-474.
25. MEISCH, H.U. and WANNEMACHER, B. 1986, Fluorometric determination of 5-aminolevulinic acid after derivatization with o-phthaldialdehyde and separation by reversed-phase high-performance liquid chromatography. Analytical Chemistry, 58, 1372-1375.
26. MEISCH, H.U., REINLE, W. and Wolf, U. 1985, Determination of 5-aminolevulinic acid in biological samples by high-performance liquid chromatography. Analytical Biochemistry, 149, 29-34.
27. MINDER, E.I. 1986, Measurement of 5-aminolevulinic acid by reversed phase HPLC and fluorescence detection. Clinica Chimica Acta, 161, 11-18.
28. MORITA, Y., ARAKI, S., SAKAI, T., ARAKI, T. and MASUYAMA, Y. 1994, Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects. Industrial Health, 32, 85-96.
29. MULLER, W.E. and SNYDER, S.H. 1997, δ-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Annals of Neurology, 2, 340-342.
30. NISHIMA, T. 1977, A method for screening of lead exposure using spot urine sample based on relationship between δ-ALA and creatinine excretion. Japanese Journal of Hygiene, 32(2), 398-405 [in Japanese].
31. OKAYAMA, A., LIM, K.M. and GOTO, S. 1986, Fluorophotometric determination of δ-aminolevulinic acid in urine by reversed-phase high-performance liquid chromatography. Igakuno Ayumi, 139, 845-846 [in Japanese].
32. PRPIC-MAJIC, D., PONGRACIC, J., HRSAK, J. and PIZENT, A. 1992, A follow-up study in a lead smelter community following the introduction of an effective pollution control system. Israeli Journal of Medical Science, 28, 548-556.
33. SILBERGELD, E.K. and LAMON, J.M. 1980, Role of altered heme synthesis in lead neurotoxicity. Journal of Occupational Medicine, 22, 680-684.
34. SILBERGELD, E.K. and LAMON, J.M. 1982, Effects of altered porphyrin synthesis on brain neurochemistry. Neurobehavioral Toxicology and Teratology, 4, 635-642.
35. THUNELL, S., HOLMBERG, L. and LUNDGREN, J. 1987, Aminolaevulinate dehydratase porphyria in infancy. A clinical and biochemical study. Journal of Clinical Chemistry and Clinical Biochemistry, 25, 5-14.
36. TOMOKUNI, K., ICHIBA, M., HIRAI, Y. and HASEGAWA. T. 1987, Optimized liquid-chromatographic method for fluorometric determination of urinary δ-aminolevulinic acid in workers exposed to lead. Clinical Chemistry, 33(9), 1665-1667.
37. TOMOKUNI, K., ICHIBA, M. and HIRAI, Y. 1992, Measurement of urinary δ-aminolevulinic acid (ALA) by fluorometric HPLC and colorimetric methods. Industrial Health, 30, 119-128.
38. TOMOKUNI, K., ICHIBA, M. and HIRAI, Y. 1993a, HPLC micro-method for determining δ-aminolevulinic acid in plasma. Clinical Chemistry ,39(1), 169-170.
39. TOMOKUNI, K., ICHIBA, M. and FUJISHIRO. K. 1993b, Interrelation between urinary δ-aminolevulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead. Industrial Health, 31, 51-57.
40. WATANABE, T., KASAHARA, M., NAKATSUKA. H. and IKEDA, M. 1987, Cadmium and lead contents of cigarettes produced in various areas of the world. The Science of the Total Environment, 66, 29-37.
41. WEAVER, V.M., DAVOLI, C.T., HELLER, P.J., FITZWILLIAM, A., PETERS, H.L., SUNYER, J., MURPHY, S.E., GOLDSTEIN, G. W. and GROOPMAN, J.D. 1995, Benzene exposure, assessed by urinary trans,trans-muconic acid, in urban children with elevated blood lead levels. Environmental Health Perspectives, 104, 318-323.
42. WITTING, U., BINDING, N. and MÜLLER, G. 1987, Evaluation of a new specific analysis of urinary delta-aminolevulinic acid in man. International Archives of Occupational and Environmental Health, 59, 375-383.
43. WORLD HEALTH ORGANIZATION 1977, Environmental Health Criteria 3: Lead (Geneva: World Health Organization), pp. 53-54.
44. YEUNG LAIWAH, A.C., MOORE, M.R. and GOLDBERG, A. 1987, Pathogenesis of acute porphyria. Quarterly Journal of Medicine, New Series, 63(241), 377-392.